ArticleArthritis & rheumatology (Hoboken, N.J.)2017

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.

Karen Hambardzumyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.